Delivery Order SPE2DB22D2005-SPE2DB25FJNE8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, non-set-aside contract with performance occurring at the company's corporate office in Conshohocken, Pennsylvania. The award represents a competitive delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,881.75 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,716.59. The award, issued on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a non-set-aside competitive procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Viberzi 100 mg tablets (60-count packages) with a ceiling value of $3,030.63. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order is scheduled for completion by June 6, 2025, and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $2,089.66. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Viberzi 75 mg tablets (60 count) valued at $2,354.21. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Viberzi 100 mg tablets (60-count) valued at $1,914.82. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026. The order is set to be completed by June 3, 2025, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Viberzi 100 mg tablets (60-count) with a ceiling value of $1,911.21. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation, and performance will be...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100mg, with a ceiling value of $2,276.80. This competitive award, effective August 12, 2025, with an ultimate completion date of August 13, 2025, was executed under firm fixed-price terms with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Viberzi 100 mg tablets (60-count) at a ceiling value of $3,587.92 under a firm fixed price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively determined with no...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJNE8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,798.21 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 75 mg on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. Viberzi is a brand-name medication used in the treatment of irritable bowel syndrome with diarrhea, representing the type of specialty pharmaceutical products that AmerisourceBergen supplies through its extensive federal contract portfolio. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen fulfills diverse medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through its prime vendor contracts. This delivery order exemplifies the company's role in supporting the federal medical supply chain with rapid fulfillment of pharmaceutical requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/4/25 |